SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011590
Filing Date
2024-08-08
Accepted
2024-08-08 16:06:09
Documents
93
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20240630x10q.htm   iXBRL 10-Q 1894169
2 EX-31.1 irwd-20240630xex31d1.htm EX-31.1 16579
3 EX-31.2 irwd-20240630xex31d2.htm EX-31.2 16666
4 EX-32.1 irwd-20240630xex32d1.htm EX-32.1 7976
5 EX-32.2 irwd-20240630xex32d2.htm EX-32.2 8439
  Complete submission text file 0001558370-24-011590.txt   8673682

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20240630.xsd EX-101.SCH 77811
7 EX-101.CAL irwd-20240630_cal.xml EX-101.CAL 76252
8 EX-101.DEF irwd-20240630_def.xml EX-101.DEF 324604
9 EX-101.LAB irwd-20240630_lab.xml EX-101.LAB 566032
10 EX-101.PRE irwd-20240630_pre.xml EX-101.PRE 501144
96 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20240630x10q_htm.xml XML 1386437
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 241188207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)